Product Name

  • Name

    DOTA

  • EINECS 611-959-5
  • CAS No. 60239-18-1
  • Article Data31
  • CAS DataBase
  • Density 1.321 g/cm3
  • Solubility
  • Melting Point 267 °C
  • Formula C16H28N4O8
  • Boiling Point 701.6 °C at 760 mmHg
  • Molecular Weight 404.42
  • Flash Point 378.1 °C
  • Transport Information
  • Appearance
  • Safety 26-36
  • Risk Codes 36/37/38
  • Molecular Structure Molecular Structure of 60239-18-1 (DOTA)
  • Hazard Symbols IrritantXi
  • Synonyms 1,4,7,10-Tetra(carboxymethyl)-1,4,7,10-tetraazacyclododecane;1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid;DOTA;NSC681107;Tetraxetan;
  • PSA 162.16000
  • LogP -2.70200

Synthetic route

1,4,7-tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane-10-acetic acid
137076-54-1

1,4,7-tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane-10-acetic acid

A

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

B

tert-butyl alcohol
75-65-0

tert-butyl alcohol

Conditions
ConditionsYield
With chlorotriisopropylsilane; water; trifluoroacetic acid for 3h; Time; Reagent/catalyst; Solvent;A 100%
B 100%
C43H58N4O8
1412494-57-5

C43H58N4O8

A

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

B

1-methyl-1-phenylethyl alcohol
617-94-7

1-methyl-1-phenylethyl alcohol

Conditions
ConditionsYield
With chlorotriisopropylsilane; water; trifluoroacetic acid for 0.833333h; Time; Reagent/catalyst; Solvent;A 100%
B 100%
2-(4,7,10-tris(2-(tert-butoxy)-2-oxoethyl)-1,4,7,10-tetraazacyclododecan-1-yl)acetic acid

2-(4,7,10-tris(2-(tert-butoxy)-2-oxoethyl)-1,4,7,10-tetraazacyclododecan-1-yl)acetic acid

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

Conditions
ConditionsYield
With trifluoroacetic acid In dichloromethane for 12h;89%
With trifluoroacetic acid In dichloromethane at 20℃; for 16h;85%
With trifluoroacetic acid In dichloromethane at 20℃;
chloroacetic acid
79-11-8

chloroacetic acid

1,4,7,10-tetraazacyclododecan
294-90-6

1,4,7,10-tetraazacyclododecan

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

Conditions
ConditionsYield
With sodium hydroxide In water at 70℃; for 30h; pH=9.5 - 10;88%
With (-)-cycleanine; sodium hydroxide In water at 80 - 85℃; pH=10 - 11; Large scale;82.7%
With sodium hydroxide In water at 80 - 85℃; pH=10 - 11; Industrial scale;82.7%
bromoacetic acid
79-08-3

bromoacetic acid

1,4,7,10-tetraazacyclododecan
294-90-6

1,4,7,10-tetraazacyclododecan

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

Conditions
ConditionsYield
With lithium hydroxide monohydrate; water at 0 - 30℃; for 24h; Temperature; Reagent/catalyst;87.8%
tetraethyl 2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetate

tetraethyl 2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetate

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

Conditions
ConditionsYield
With water; sodium hydroxide In methanol at 55 - 60℃; for 12h;80.5%
Iodoacetic acid
64-69-7

Iodoacetic acid

1,4,7,10-tetraazacyclododecan
294-90-6

1,4,7,10-tetraazacyclododecan

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

Conditions
ConditionsYield
With lithium hydroxide monohydrate; water at 0 - 30℃; for 24h;72%
chloroacetic acid lithium salt
19326-51-3

chloroacetic acid lithium salt

1,4,7,10-tetraazacyclododecan
294-90-6

1,4,7,10-tetraazacyclododecan

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

Conditions
ConditionsYield
With lithium hydroxide monohydrate; water at 0 - 30℃; for 24h;43.8%
bromoacetic acid methyl ester
96-32-2

bromoacetic acid methyl ester

1,4,7,10-tetraazacyclododecan
294-90-6

1,4,7,10-tetraazacyclododecan

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

Conditions
ConditionsYield
With lithium hydroxide monohydrate; water at 0 - 30℃; for 24h;32.5%
ethyl bromoacetate
105-36-2

ethyl bromoacetate

1,4,7,10-tetraazacyclododecan
294-90-6

1,4,7,10-tetraazacyclododecan

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

Conditions
ConditionsYield
With lithium hydroxide monohydrate; water at 0 - 30℃; for 24h;24.8%
1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid mono(4-nitrophenyl) ester
474424-15-2

1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid mono(4-nitrophenyl) ester

A

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

B

4-nitro-phenol
100-02-7

4-nitro-phenol

Conditions
ConditionsYield
In water for 1h; pH=7; Kinetics; Further Variations:; pH-values;
N,N',N'',N'''-tetrakis-(p-tolylsulphonyl)-triethylenetetramine
55442-07-4

N,N',N'',N'''-tetrakis-(p-tolylsulphonyl)-triethylenetetramine

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 78 percent / K2CO3 / dimethylformamide / 30 h / 100 °C
2: 33 percent / conc. H2SO4 / 28 h / 115 °C
3: 88 percent / NaOH / H2O / 30 h / 70 °C / pH 9.5 - 10
View Scheme
cyclen tetratosylate
52667-88-6

cyclen tetratosylate

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 33 percent / conc. H2SO4 / 28 h / 115 °C
2: 88 percent / NaOH / H2O / 30 h / 70 °C / pH 9.5 - 10
View Scheme
triethylentetramine
112-24-3

triethylentetramine

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 97 percent / Et3N / acetonitrile / 5 h / 20 °C
2: 78 percent / K2CO3 / dimethylformamide / 30 h / 100 °C
3: 33 percent / conc. H2SO4 / 28 h / 115 °C
4: 88 percent / NaOH / H2O / 30 h / 70 °C / pH 9.5 - 10
View Scheme
2Na(1+)*Pb(2+)*(N(CH2COO)C2H4)4(4-)*2H2O=Na2Pb(N(CH2COO)C2H4)4*2H2O

2Na(1+)*Pb(2+)*(N(CH2COO)C2H4)4(4-)*2H2O=Na2Pb(N(CH2COO)C2H4)4*2H2O

A

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

B

lead(2+) cation

lead(2+) cation

Conditions
ConditionsYield
In perchloric acid Kinetics; decompn. of Pb compd. in aq. HClO4 depending from acid concn.;
C46H62N4O8
1412494-56-4

C46H62N4O8

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: tetrakis(triphenylphosphine) palladium(0); 4-methyl-morpholine / dichloromethane / 3 h / 20 °C
2: chlorotriisopropylsilane; trifluoroacetic acid; water / 0.83 h
View Scheme
(1,4,7,10-tetraaza-cyclododec-1-yl)-acetic acid allyl ester
1023970-58-2

(1,4,7,10-tetraaza-cyclododec-1-yl)-acetic acid allyl ester

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: potassium carbonate / acetonitrile / 16 h / 20 °C
2: tetrakis(triphenylphosphine) palladium(0); 4-methyl-morpholine / dichloromethane / 2 h / 20 °C
3: chlorotriisopropylsilane; trifluoroacetic acid; water / 3 h
View Scheme
Multi-step reaction with 3 steps
1: potassium carbonate / acetonitrile / 8 h / 20 °C
2: tetrakis(triphenylphosphine) palladium(0); 4-methyl-morpholine / dichloromethane / 3 h / 20 °C
3: chlorotriisopropylsilane; trifluoroacetic acid; water / 0.83 h
View Scheme
C31H56N4O8
1412494-55-3

C31H56N4O8

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: tetrakis(triphenylphosphine) palladium(0); 4-methyl-morpholine / dichloromethane / 2 h / 20 °C
2: chlorotriisopropylsilane; trifluoroacetic acid; water / 3 h
View Scheme
1,4,7,10-tetraazacyclododecan
294-90-6

1,4,7,10-tetraazacyclododecan

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: potassium carbonate / chloroform / 52 h / 20 °C
2: trifluoroacetic acid / dichloromethane / 12 h
View Scheme
Multi-step reaction with 2 steps
1: potassium carbonate / acetonitrile / 40 h / Reflux
2: sodium hydroxide; water / methanol / 12 h / 55 - 60 °C
View Scheme
Multi-step reaction with 2 steps
1: chloroform / 72 h / 20 °C
2: trifluoroacetic acid / dichloromethane / 20 °C
View Scheme
cyclen hydrochloride

cyclen hydrochloride

chloroacetic acid
79-11-8

chloroacetic acid

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

Conditions
ConditionsYield
With sodium hydroxide In water at 0 - 75℃; pH=10 - 10.5;
Stage #1: cyclen hydrochloride; chloroacetic acid With hydrogenchloride; sodium hydroxide In water at 0 - 75℃; pH=10 - 10.5;
Stage #2: In water pH=2.5 - 3;
With sodium hydroxide In water at 10 - 30℃; for 24h; Reagent/catalyst;
sodium monochloroacetic acid
3926-62-3

sodium monochloroacetic acid

1,4,7,10-tetraazacyclododecan
294-90-6

1,4,7,10-tetraazacyclododecan

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

Conditions
ConditionsYield
With sodium hydroxide In water for 5h; pH=11; Concentration; Large scale;
With lithium hydroxide monohydrate; water at 0 - 30℃; for 24h;
sodium 2-bromoacetate
1068-52-6

sodium 2-bromoacetate

1,4,7,10-tetraazacyclododecan
294-90-6

1,4,7,10-tetraazacyclododecan

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

Conditions
ConditionsYield
With lithium hydroxide monohydrate; water at 0 - 30℃; for 24h;
potassium iodoacetate
15973-59-8

potassium iodoacetate

1,4,7,10-tetraazacyclododecan
294-90-6

1,4,7,10-tetraazacyclododecan

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

Conditions
ConditionsYield
With lithium hydroxide monohydrate; water at 0 - 30℃; for 24h;
monosodium iodoacetate
305-53-3

monosodium iodoacetate

1,4,7,10-tetraazacyclododecan
294-90-6

1,4,7,10-tetraazacyclododecan

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

Conditions
ConditionsYield
With lithium hydroxide monohydrate; water at 0 - 30℃; for 24h;
1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

gadolinium(III) chloride hexahydrate

gadolinium(III) chloride hexahydrate

gadoteric acid
72573-82-1

gadoteric acid

Conditions
ConditionsYield
With potassium hydroxide In water at 60℃; for 24h; pH=5.5 - 7;100%
1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

manganese (II) sulfate monohydrate

manganese (II) sulfate monohydrate

Mn(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid(2-))*2H2O

Mn(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid(2-))*2H2O

Conditions
ConditionsYield
In water MnSO4*H2O dissolved in H2O, ligand added, stirred for 30 min; H2O evapd.; elem. anal.;99%
1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

scandium(III) acetate
3804-23-7

scandium(III) acetate

sodium hydroxide
1310-73-2

sodium hydroxide

3(Na[Sc(1,4,7,10-tetra-azacyclododecane-N,N',N'',N'''-tetraacetate)])*NaOH*18H2O

3(Na[Sc(1,4,7,10-tetra-azacyclododecane-N,N',N'',N'''-tetraacetate)])*NaOH*18H2O

Conditions
ConditionsYield
In water to aq. suspn. H4DOTA NaOH was added until pH 5, Sc(acetate)3 was added and heated at 60°C for 12 h at pH 4; soln. was concd., residue was dissolved in water, basified with NaOH at pH 7.0 and evapd. to dryness under reduced pressure;95%
lanthanum(III) oxide

lanthanum(III) oxide

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

sodium hydroxide
1310-73-2

sodium hydroxide

Na(1+)*2La(3+)*C8H16N4(CH2CO2)4(4-)*C8H16N4(CH2CO2)3CH2CO2H(3-)*10H2O=Na[La2(C8H16N4(CH2CO2)4)2H]*10H2O

Na(1+)*2La(3+)*C8H16N4(CH2CO2)4(4-)*C8H16N4(CH2CO2)3CH2CO2H(3-)*10H2O=Na[La2(C8H16N4(CH2CO2)4)2H]*10H2O

Conditions
ConditionsYield
In water stoich. amts., 85°C, stirring for several d; cooling to room temp., filtration, evapn. (reduced pressure);93%
gadolinium(III) oxide

gadolinium(III) oxide

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

1-deoxy-1-(methylamino)-D-glucitol
6284-40-8

1-deoxy-1-(methylamino)-D-glucitol

gadoterate meglumine

gadoterate meglumine

Conditions
ConditionsYield
Stage #1: 1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane; 1-deoxy-1-(methylamino)-D-glucitol In water for 0.05h; Green chemistry;
Stage #2: gadolinium(III) oxide In water for 0.283333h; Sonication; Green chemistry;
89%
morpholine
110-91-8

morpholine

gadolinium(III) oxide

gadolinium(III) oxide

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

gadoterate morpholine

gadoterate morpholine

Conditions
ConditionsYield
Stage #1: morpholine; 1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane In water for 0.05h; Sonication; Green chemistry;
Stage #2: gadolinium(III) oxide In water for 0.283333h; Sonication; Green chemistry;
85%
gadolinium(III) oxide

gadolinium(III) oxide

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

Na(1+)*Gd(3+)*(CH2CH2N(CH2COO))4(4-)*H2O*4H2O=Na{Gd(CH2CH2N(CH2COO))4H2O}*4H2O

Na(1+)*Gd(3+)*(CH2CH2N(CH2COO))4(4-)*H2O*4H2O=Na{Gd(CH2CH2N(CH2COO))4H2O}*4H2O

Conditions
ConditionsYield
In water Gd2O3 and tetraazacyclododecanetetraacetic acid soln. was stirred at 368 K for 2 h, NaOH was slowly added at room temp. to pH 7 with stirring; after filtration mixt. was concd. in vac. and pptd. with acetone; recrystn. from hot H2O/acetone; elem. anal.;83%
gadolinium(III) oxide

gadolinium(III) oxide

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

1-deoxy-1-(methylamino)-D-glucitol
6284-40-8

1-deoxy-1-(methylamino)-D-glucitol

gadoteric dcid meglumine

gadoteric dcid meglumine

Conditions
ConditionsYield
In water at 40 - 50℃; for 3h; pH=7 - 9; Industrial scale;82%
1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

nickel(II)

nickel(II)

{(CH2CH2)NCH2COOH}2{(CH2CH2)NCH2COO}2Ni
107171-59-5

{(CH2CH2)NCH2COOH}2{(CH2CH2)NCH2COO}2Ni

Conditions
ConditionsYield
In water equimolar amounts of ligand and metal salt; pH 2.5;; crystallization after several days; elem. anal.;;80%
gadolinium(III) oxide

gadolinium(III) oxide

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

(2S,3S,4S,5R)-6-(methylamino)hexane-1,2,3,4,5-pentaol

(2S,3S,4S,5R)-6-(methylamino)hexane-1,2,3,4,5-pentaol

gadoteric dcid meglumine

gadoteric dcid meglumine

Conditions
ConditionsYield
In water at 40 - 50℃; for 3h; pH=7 - 9; Large scale;78.5%
1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

p-xylylidenediamine
539-48-0

p-xylylidenediamine

2,2',2''-(10-(2-(4-(aminomethyl)benzylamino)-2-oxoethyl)-1,4,7,10-tetraazacyclo-dodecane-1,4,7-triyl)triacetic acid
1314043-15-6

2,2',2''-(10-(2-(4-(aminomethyl)benzylamino)-2-oxoethyl)-1,4,7,10-tetraazacyclo-dodecane-1,4,7-triyl)triacetic acid

Conditions
ConditionsYield
With pyridine; diisopropyl-carbodiimide In water; acetonitrile75%
1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

zinc(II) cation

zinc(II) cation

(1,4,7,10-tetraazacyclododecane-N,N',N''-N'''-dihydrogentetraacetato)zinc
107171-57-3, 277333-19-4

(1,4,7,10-tetraazacyclododecane-N,N',N''-N'''-dihydrogentetraacetato)zinc

Conditions
ConditionsYield
In water equimolar amounts of ligand and metal salt; pH 2.5;; crystallization after several days; elem. anal.;;72%
1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

2-AMINOETHYL TRIMETHYLAMMONIUM CHLORIDE
10256-43-6

2-AMINOETHYL TRIMETHYLAMMONIUM CHLORIDE

10-<2-(trimethylammonio)ethylcarbamoylmetyhyl>-1,4,7,10-tetraazacyclododecane-1,4,7-tri(triacetic acid) chloride

10-<2-(trimethylammonio)ethylcarbamoylmetyhyl>-1,4,7,10-tetraazacyclododecane-1,4,7-tri(triacetic acid) chloride

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In pyridine; acetonitrile at 20℃; for 48h;71%
1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

copper(II) ion

copper(II) ion

{(CH2CH2)NCH2COOH}2{(CH2CH2)NCH2COO}2Cu
107171-58-4, 277333-30-9

{(CH2CH2)NCH2COOH}2{(CH2CH2)NCH2COO}2Cu

Conditions
ConditionsYield
In water equimolar amounts of ligand and metal salt; pH 2.5;; crystallization after several days; elem. anal.;;69%
gadolinium(III) oxide

gadolinium(III) oxide

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

gadolinium(III) 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid
72573-82-1

gadolinium(III) 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid

Conditions
ConditionsYield
In water for 3h;67.9%
In water addn. of gadolinium oxide to aq. soln. of tetraazacyclododecane deriv., mixt. heated at 90°C for 12 h; cooling to room temp., addn. of cation-exchange and anion-exchange resins, stirring for 60 min at room temp., filtration, filtrate freeze dried;61%
1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

NO2(C6H4)CH2CH(C(O)NHCH2CH2NH2)NHC(O)(C6H4)((C9BN2)(F)2(CH3)4(CH2CH3)2)

NO2(C6H4)CH2CH(C(O)NHCH2CH2NH2)NHC(O)(C6H4)((C9BN2)(F)2(CH3)4(CH2CH3)2)

NO2(C6H4)CH2CH(C(O)NHCH2CH2NHC(O)CH2(C8H16N4)(CH2C(O)OH)3)NHC(O)(C6H4)((C9BN2)(F)2(CH3)4(CH2CH3)2)

NO2(C6H4)CH2CH(C(O)NHCH2CH2NHC(O)CH2(C8H16N4)(CH2C(O)OH)3)NHC(O)(C6H4)((C9BN2)(F)2(CH3)4(CH2CH3)2)

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 20℃; for 12h;65%
1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

3-bromopropyl biotin
1296869-99-2

3-bromopropyl biotin

C29H48N6O11S

C29H48N6O11S

Conditions
ConditionsYield
With 1,8-diazabicyclo[5.4.0]undec-7-ene In acetonitrile at 82℃; for 18h;65%
1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

3-amino-deoxycombretastatin A4
162705-07-9

3-amino-deoxycombretastatin A4

C34H47N5O11

C34H47N5O11

Conditions
ConditionsYield
Stage #1: 1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane With thionyl chloride for 4h; Reflux;
Stage #2: 3-amino-deoxycombretastatin A4 With N-ethyl-N,N-diisopropylamine In dichloromethane at 30℃; for 3h; Cooling with ice;
65%
1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

N,N-bis(ethoxycarbonylmethyl)ethylenediamine

N,N-bis(ethoxycarbonylmethyl)ethylenediamine

(Ethoxycarbonylmethyl-{2-[2-(4,7,10-tris-{[2-(bis-ethoxycarbonylmethyl-amino)-ethylcarbamoyl]-methyl}-1,4,7,10-tetraaza-cyclododec-1-yl)-acetylamino]-ethyl}-amino)-acetic acid ethyl ester

(Ethoxycarbonylmethyl-{2-[2-(4,7,10-tris-{[2-(bis-ethoxycarbonylmethyl-amino)-ethylcarbamoyl]-methyl}-1,4,7,10-tetraaza-cyclododec-1-yl)-acetylamino]-ethyl}-amino)-acetic acid ethyl ester

Conditions
ConditionsYield
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; triethylamine In chloroform; N,N-dimethyl-formamide at 20℃; for 30h;63%
1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

copper(ll) sulfate pentahydrate

copper(ll) sulfate pentahydrate

{(CH2CH2)NCH2COO}4(4-)*2Cu(2+)*5H2O={(CH2CH2)NCH2COO}4Cu2*5H2O

{(CH2CH2)NCH2COO}4(4-)*2Cu(2+)*5H2O={(CH2CH2)NCH2COO}4Cu2*5H2O

Conditions
ConditionsYield
In water pH=4; stochiometric amounts;; after 2-3 days crystallization; elem. anal.;;60%
1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

Met-OMe
10332-17-9

Met-OMe

C40H72N8O12S4

C40H72N8O12S4

Conditions
ConditionsYield
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 24h;55%
1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
60239-18-1

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane

gadolinium(III) trifluoromethanesulfonate

gadolinium(III) trifluoromethanesulfonate

gadolinium 2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetic acid
783303-01-5, 83678-67-5, 881694-36-6, 881694-49-1

gadolinium 2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetic acid

Conditions
ConditionsYield
With triethylamine In methanol at 45℃; for 48h;55%

Tetraxetan Specification

The 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraaceticacid, with its CAS registry number 60239-18-1, has the IUPAC name of 2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid. Being a kind of colourless crystals, its product categories are including Azacrown Ethers; Functional Materials; Macrocycles for Host-Guest Chemistry.

The characteristics of this chemical are as below: (1)ACD/LogP: -1.31; (2)# of Rule of 5 Violations: 1; (3)ACD/LogD (pH 5.5): -5.52; (4)ACD/LogD (pH 7.4): -6.31; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 1; (8)ACD/KOC (pH 7.4): 1; (9)#H bond acceptors: 12; (10)#H bond donors: 4; (11)#Freely Rotating Bonds: 8;  (12)Polar Surface Area: 118.16; (13)Index of Refraction: 1.531; (14)Molar Refractivity: 94.72 cm3; (15)Molar Volume: 305.9 cm3; (16)Polarizability: 37.55×10-24 cm3; (17)Surface Tension: 55.6 dyne/cm; (18)Density: 1.321 g/cm3; (19)Flash Point: 378.1 °C; (20)Enthalpy of Vaporization: 111.87 kJ/mol; (21)Boiling Point: 701.6 °C at 760 mmHg; (22)Vapour Pressure: 1.51E-21 mmHg at 25°C; (23)Exact Mass: 404.190714; (24)MonoIsotopic Mass: 404.190714; (25)Topological Polar Surface Area: 162; (26)Heavy Atom Count: 28; (27)Complexity: 447.

Use of this chemical: 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraaceticacid could react with (3aS,4S,6aR)-N-(6-aminohexyl)hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentamine to produce 10-[2-[6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-1-yl]-1-pentylamino]-1-hexylamino]-2-oxoethyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid. This reaction could happen in the presence of the reagent of N-hydroxysulfosuccinimide sodium salt, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide and aq. NaOH, and the solvent of H2O. And it needs the reaction time of 20 min-2 hours and the reaction temperature of 20 ℃. Besides, it requires the PH value of 5.5-7.5 with the yield of 45.6%.

When you are dealing with this kind of chemical, you should be cautious. This is a kind of irritant chemical which is irritating to eyes, respiratory system and skin and it may cause inflammation to the skin or other mucous membranes. Therefore, you should wear suitable gloves and eye/face protection. And if in case of contact with eyes, rinse immediately with plenty of water and seek medical advice.

In addition, you could convert the following datas into the molecular structure:
(1)Canonical SMILES: C1CN(CCN(CCN(CCN1CC(=O)O)CC(=O)O)CC(=O)O)CC(=O)O
(2)InChI: InChI=1S/C16H28N4O8/c21-13(22)9-17-1-2-18(10-14(23)24)5-6-20(12-16(27)28)8-7-19(4-3-17)11-15(25)26/h1-12H2,(H,21,22)(H,23,24)(H,25,26)(H,27,28)
(3)InChIKey: WDLRUFUQRNWCPK-UHFFFAOYSA-N 

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View